Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
1,779
datasets available to search
ShareScore release 0.9.0
Dataset results
1,779 results for “Hodgkin lymphoma”
Study to Evaluate Safety, Tolerability, and Pharmacokinetics of Idelalisib in Japanese Participants With Relapsed or Refractory Indolent B-Cell Non-Hodgkin Lymphomas (iNHL) or Chronic Lymphocytic Leuk
ClinicalTrials.gov study NCT02242045. IPD Sharing: YES. Countries: 1. Publications: 1.
Lenalidomide and Rituximab in Treating Patients With Previously Untreated Stage II, Stage III, or Stage IV Follicular Non-Hodgkin Lymphoma
ClinicalTrials.gov study NCT01145495. IPD Sharing: Not stated. Countries: 1. Publications: 3.
Vemurafenib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With BRAF V600 Mutations (A Pediatric MATCH Treatment Trial)
ClinicalTrials.gov study NCT03220035. IPD Sharing: Not stated. Countries: 2. Publications: 2.
Pilot Study of Bortezomib, Bendamustine and Rituximab on Non-Hodgkin's Lymphoma
ClinicalTrials.gov study NCT00547534. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Rituximab in Treating Patients With Low Tumor Burden Indolent Non-Hodgkin's Lymphoma
ClinicalTrials.gov study NCT00075946. IPD Sharing: Not stated. Countries: 1. Publications: 2.
Multicenter Trial to Treat Patients With Relapsed/Refractory Aggressive Non Hodgkin Lymphoma
ClinicalTrials.gov study NCT00884286. IPD Sharing: NO. Countries: 6. Publications: 1.
MAXIMA Study: A Study of Maintenance Therapy With MabThera (Rituximab) in Patients With Non-Hodgkin's Lymphoma.
ClinicalTrials.gov study NCT00430352. IPD Sharing: Not stated. Countries: 24. Publications: 1.
BI 836826 Dose Escalation in Patients With Relapsed or Refractory Non-Hodgkin Lymphoma (NHL)
ClinicalTrials.gov study NCT01403948. IPD Sharing: Not stated. Countries: 3. Publications: 1.
Brentuximab Vedotin Before Autologous Stem Cell Transplant in Treating Patients With Hodgkin Lymphoma
ClinicalTrials.gov study NCT01393717. IPD Sharing: Not stated. Countries: 1. Publications: 2.
A Study to Compare the Efficacy and Safety of JCAR017 to Standard of Care in Adult Subjects With High-risk, Transplant-eligible Relapsed or Refractory Aggressive B-cell Non-Hodgkin Lymphomas
ClinicalTrials.gov study NCT03575351. IPD Sharing: Not stated. Countries: 12. Publications: 7.
Ofatumumab and Bendamustine Hydrochloride With or Without Bortezomib in Treating Patients With Untreated Follicular Non-Hodgkin Lymphoma
ClinicalTrials.gov study NCT01286272. IPD Sharing: Not stated. Countries: 1. Publications: 2.
Brentuximab Vedotin and Combination Chemotherapy in Treating Patients With Stage II-IV HIV-Associated Hodgkin Lymphoma
ClinicalTrials.gov study NCT01771107. IPD Sharing: Not stated. Countries: 2. Publications: 2.
Immunotherapy (Nivolumab or Brentuximab Vedotin) Plus Combination Chemotherapy in Treating Patients With Newly Diagnosed Stage III-IV Classic Hodgkin Lymphoma
ClinicalTrials.gov study NCT03907488. IPD Sharing: YES. Countries: 3. Publications: 2.
Adcetris (Brentuximab Vedotin), Combination Chemotherapy, and Radiation Therapy in Treating Younger Patients With Stage IIB, IIIB and IV Hodgkin Lymphoma
ClinicalTrials.gov study NCT01920932. IPD Sharing: Not stated. Countries: 1. Publications: 2.
Dose-Adjusted EPOCH Chemotherapy and Rituximab (CD20+) in Previously Untreated Aggressive Non-Hodgkin's Lymphoma
ClinicalTrials.gov study NCT00001337. IPD Sharing: YES. Countries: 1. Publications: 10.
S0816 Fludeoxyglucose F 18-PET/CT Imaging and Combination Chemotherapy With or Without Additional Chemotherapy and G-CSF in Treating Patients With Stage III or Stage IV Hodgkin Lymphoma
ClinicalTrials.gov study NCT00822120. IPD Sharing: Not stated. Countries: 1. Publications: 3.
Trial to Determine the Efficacy and Safety of JCAR017 in Adult Participants With Aggressive B-Cell Non-Hodgkin Lymphoma
ClinicalTrials.gov study NCT03484702. IPD Sharing: Not stated. Countries: 11. Publications: 1.
Etoposide, Methylprednisolone, High-dose Cytarabine and Oxaliplatin as 2nd Line Therapy for Non-Hodgkin's Lymphoma (NHL)
ClinicalTrials.gov study NCT00336583. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Alisertib in Treating Patients With Relapsed or Refractory Peripheral T-Cell Non-Hodgkin Lymphoma
ClinicalTrials.gov study NCT01466881. IPD Sharing: Not stated. Countries: 2. Publications: 1.
A Study of Polatuzumab Vedotin in Combination With Rituximab or Obinutuzumab, Cyclophosphamide, Doxorubicin, and Prednisone in Participants With B-Cell Non-Hodgkin's Lymphoma
ClinicalTrials.gov study NCT01992653. IPD Sharing: Not stated. Countries: 2. Publications: 2.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.